John Vu
Family Medicine · McDonough, GANPI 1457458085
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations.
Across 108 payments — averaging $23.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$577
- Revance Therapeutics, Inc.$261
- Novo Nordisk$248
- AstraZeneca$228
- AbbVie$171
- Boehringer Ingelheim$169
- plus $917 from 13 others
Across 104 payments — averaging $3593.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$358K
- AstraZeneca$16K
What the payments were for
- Food & beverage$2,573100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 31 | $577 |
| Revance Therapeutics, Inc. | 4 | $261 |
| Novo Nordisk | 17 | $248 |
| AstraZeneca | 7 | $228 |
| AbbVie(2 entities) | 11 | $171 |
| Boehringer Ingelheim | 9 | $169 |
| Vertos Medical, Inc. | 1 | $143 |
| Medtronic | 1 | $120 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $115 |
| Sanofi-aventis U.S. LLC | 7 | $112 |
| Gilead | 1 | $96 |
| Biogen | 5 | $92 |
| Bayer | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Corcept Therapeutics | 1 | $31 |
| Shire North American Group Inc | 1 | $22 |
| Dexcom, Inc. | 1 | $15 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$143
- DAXXIFY$141
- FARXIGA$123
- INTELLIS ADAPTIVESTIM$120
- LUCEMYRA$115
How this compares
$2,573 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atovaquone-Proguanil HclAtovaquone/Proguanil Hcl | 274 | $17,784 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $14,475 |
| Yf-VaxYellow Fever Vaccine Live/Pf | 11 | $4,289 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $1,695 |
| Gabapentin | 28 | $1,140 |
| Azithromycin | 192 | $578 |
| Doxycycline Hyclate | 20 | $552 |
| Naltrexone Hcl | 11 | $529 |
| Tamsulosin Hcl | 17 | $190 |
| Metoprolol Succinate | 11 | $141 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $129 |
| Tramadol Hcl | 12 | $121 |
| Pregabalin | 24 | $120 |
| Amlodipine Besylate | 25 | $109 |
| Tizanidine Hcl | 19 | $84 |
Paid to pharmacies, not to this prescriber.
Other family medicine in McDonough
- Jeffrey KingsleyColumbus$404K
- Debbie HaginsSavannah$279K
- Yolanda WadeTyrone$233K
- Julian HutchinsWarrenton$222K
- Nadine Halliburton-FosterCumming$219K
- Contessa MetcalfeAtlanta$157K
- Elmore AlexanderStone Mountain$155K
- Bantwal BaligaColumbus$115K
- Avril CampbellFort Benning$108K
- Mitzi RubinMarietta$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.